Hepatopulmonary syndrome secondary prevention: Difference between revisions
Created page with "__NOTOC__ {{Hepatopulmonary syndrome}} {{CMG}}; {{AE}} {{Soroush}}" |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hepatopulmonary syndrome}} | {{Hepatopulmonary syndrome}} | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | |||
There are no established measures for the secondary prevention of hepatopulmonary syndrome. | |||
OR | |||
Effective measures for the secondary prevention of hepatopulmonary syndrome include [strategy 1], [strategy 2], and [strategy 3]. | |||
==Secondary Prevention== | |||
There are no established measures for the secondary prevention of hepatopulmonary syndrome. | |||
OR | |||
Effective measures for the secondary prevention of hepatopulmonary syndrome include: | |||
*[Strategy 1] | |||
*[Strategy 2] | |||
*[Strategy 3] | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category: (name of the system)]] | |||
Revision as of 21:29, 3 July 2019
|
Hepatopulmonary syndrome Microchapters |
|
Differentiating Hepatopulmonary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatopulmonary syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatopulmonary syndrome secondary prevention |
|
Risk calculators and risk factors for Hepatopulmonary syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
There are no established measures for the secondary prevention of hepatopulmonary syndrome.
OR
Effective measures for the secondary prevention of hepatopulmonary syndrome include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of hepatopulmonary syndrome.
OR
Effective measures for the secondary prevention of hepatopulmonary syndrome include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]